Today

S-1/A registers 20M shares for NYSE IPO, $13.50–$16.50 price range.

Safepoint files S‑1/A registering 16,666,667 shares for a planned NYSE IPO at $15–$17 per share.

F-1/A registers 6.25M shares, $4–$6 range; Nasdaq listing is not guaranteed.

F-1/A updates IPO registration for 3,335,000 ADSs plus a 1.5M-share resale.

F-1/A registers 6.25M Class A shares; Nasdaq listing pending and governance risks highlighted.

S-1/A corrects an omitted auditor consent and references a going-concern.

S-1/A registers 5,000,000 units at $10 for FWAC SPAC IPO.

2.73M-share primary offering plus warrants will substantially dilute new investors.

S-1/A registers 70.7M shares for Nasdaq direct listing; substantial doubt disclosed.

NervGen raised its shelf to US$250M and applied to list on Nasdaq, but listing is uncertain.

Company files F-1 to sell units while Nasdaq notifies $1 bid-price deficiency.

Firefly registered 12 million shares, combining 4M new shares and 8M resale shares.

Kardigan filed an S‑1 for a Nasdaq IPO and disclosed substantial doubt about its going concern.

S-1 registers more Class A shares and details insider redemptions.

Crestone files S‑1 for a SPAC; auditor flagged going‑concern and VIE/legal risks.

LiqTech filed an S-1 to register up to $20M, citing going-concern and debt-exchange plans.

S-1 registers up to 6.3M UGRO shares for resale; filing flags liquidity and listing risks.

Eni reports termination of the first tranche and start of the second tranche of its 2026 treasury share buyback program, with reported purchases during 19–22 May 2026 totaling 3,363,076 shares (snippet).

Bleichroeder filed an F-4 registering the Pasqal merger and related warrants and convertible bonds.

Cayson filed an amended F-4 with a proxy/prospectus for a merger vote with Mango.